C. K. Osborne
Impact in
- Oncology top 5%
- HER2/EGFR in Cancer Research
- Cytokine Signaling Pathways and Interactions
- Cancer Research top 10%
- Breast Cancer Treatment Studies
Papers in
-
- RNA Research and Splicing 1
- Glycosylation and Glycoproteins Research 1
- Heat shock proteins research 1
- Gene expression and cancer classification 1
- Nuclear Structure and Function 1
- Oncology 3
- Peptidase Inhibition and Analysis 1
- Co-authors
- Rachel Schiff (3 shared papers)Jianzhong Shou (2 shared papers)Helen A. Weiss (1 shared paper)A. E. Wakeling (1 shared paper)Simak Ali (1 shared paper)Suleiman Massarweh (1 shared paper)Gary M. Clark (3 shared papers)Naomy Kim (1 shared paper)
- Journals
- JNCI Journal of the National Cancer Institute (3 papers)Breast Cancer Research and Treatment (1 paper)Endocrine Related Cancer (1 paper)Science (1 paper)PubMed (2 papers)
- Partner nations
- United StatesUnited KingdomAustralia
In The Last Decade
C. K. Osborne
8 papers receiving 1.4k citations
C. K. Osborne's Hit Papers
Peers
Comparison fields: 5 of 85
- Oncology 598
- Cancer Research 263
- Genetics 468
- Molecular Biology 683
- Immunology and Allergy 35
Countries citing papers authored by C. K. Osborne
This map shows the geographic impact of C. K. Osborne's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C. K. Osborne with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C. K. Osborne more than expected).
Fields of papers citing papers by C. K. Osborne
This network shows the impact of papers produced by C. K. Osborne. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C. K. Osborne. The network helps show where C. K. Osborne may publish in the future.
Co-authors
The 25 scholars most cited alongside C. K. Osborne, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Mechanisms of Tamoxifen Resistance: Increased Estrogen Receptor-HER2/neu Cross-Talk in ER/HER2-Positive Breast Cancer Hit paper breakdown → | 2004 | 923 |
| 2 | 1999 | 143 | |
| 3 | 1997 | 126 | |
| 4 | 1983 | 101 | |
| 5 | 1995 | 74 | |
| 6 | HET/SAF-B overexpression causes growth arrest and multinuclearity and is associated with aneuploidy in human breast cancer. | 2000 | 40 |
| 7 | 2005 | 33 | |
| 8 | Rapid identification of transfected plasmid expression vectors in cells by PCR. | 1991 | 2 |
About C. K. Osborne
C. K. Osborne is a scholar working on Molecular Biology, Oncology, Genetics, Cancer Research and Animal Science and Zoology, having authored 8 papers that have together received 1.4k indexed citations. Recurring topics across this work include RNA Research and Splicing (1 paper), Estrogen and related hormone effects (1 paper), Glycosylation and Glycoproteins Research (1 paper), Heat shock proteins research (1 paper), Gene expression and cancer classification (1 paper), Telomeres, Telomerase, and Senescence (1 paper), Nuclear Structure and Function (1 paper) and Peptidase Inhibition and Analysis (1 paper). The work is most often cited by research in Oncology (598 citations), Cancer Research (263 citations), Genetics (468 citations), Molecular Biology (683 citations) and Immunology and Allergy (35 citations). C. K. Osborne has collaborated with scholars based in United States, United Kingdom and Australia. Frequent co-authors include Rachel Schiff, Jianzhong Shou, Helen A. Weiss, A. E. Wakeling, Simak Ali, Suleiman Massarweh, Gary M. Clark, Naomy Kim, Feng Wu and Dan Levitt. Their work appears in journals such as JNCI Journal of the National Cancer Institute, Breast Cancer Research and Treatment, Endocrine Related Cancer, Science and PubMed.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.